An exploratory objective was to determine the prognostic value of PD-L1 and PD-L2 protein expression or coexpression for patients with ES-SCLC receiving usual care in Denmark before the introduction of immunotherapy. The gene discussed is CD274; the disease is small cell lung carcinoma.